Thus, part of the success of the use of fluoroquinolones in practice, and the relatively low levels of global resistance currently observed, could be because during infection, the host already triggers the LiaR response, thereby sensitizing bacteria for the antibiotic and preventing rapid selection of resistant mutants (Fig. S7). Here, ANKRD54 is linked to infection.